Closed Solicitation · DEPARTMENT OF VETERANS AFFAIRS
AI Summary
The Department of Veterans Affairs is seeking information from contractors capable of providing IV chemotherapy and hazardous drug products on an on-demand basis. This Sources Sought Announcement is for market research purposes only, and no solicitation is currently available. Interested parties must respond by email before the deadline.
THIS IS A SOURCES SOUGHT ANNOUNCEMENT ONLY. No Solicitation is currently available. All information contained in this Sources Sought Announcement is preliminary, as well as subject to modification, and is in no way binding on the Government. The Government will not pay for any information submitted in response to this request. The information requested will be used solely within the Department of Veterans Affairs to facilitate decision making and will not be disclosed outside of the Government. The determination of a procurement strategy, based upon the comments submitted in response to this Sources Sought Announcement, is solely within the discretion of the Government. The applicable North American Industry Classification System (NAICS) Code is 456110 Pharmacies and Drug Retailers, and the small business size standard is $37.5 Million. The Department of Veterans Affairs (VA) Network Contracting Office (NCO 21) is soliciting information for contractors that can provide IV chemotherapy and other hazardous drug (HD) products as requested by the VACCHCS pharmacy on an on-demand basis. A description of services is attached Statement of Work (DRAFT). Brief Description of Services See attached Statement of Work (DRAFT). Capability Statement All interested contractors must respond by email to Gary.Christensen@va.gov before 1:00 P.M. PDT on 10/03/2025. Please answer the following questions when responding: What is your company s Socioeconomic Status? (ex: small business, large business, SDVOSB, etc.) a. If SDVOSB or VOSB, are you registered with the Small Business Administration? Veteran Small Business Certification (sba.gov) Provide Company s legal name along with Unique Entity ID (SAM) number. Primary point of contact, including phone number and e-mail address. Capabilities Statement. Describe experience in providing IV chemotherapy and other hazardous drug (HD) products as described in the attached description of services. Where are services located? Can your organization meet the 3 hour delivery requirement as required in the Statement of Work? List other Projects (Government and Commercial) that are similar in scope and size. As this is a service acquisition, the Small Business Administration and the Federal Acquisition Regulation have a Limitations on Subcontracting requirement. For all small businesses, to include SDVOSB and VOSB, At least 50 percent of the cost of contract performance incurred for personnel shall be expended for employees of the concern. See FAR 52.219-14 and FAR 52.219-27 available in full text at https://www.acquisition.gov/far/html/52_217_221.html 7a. Of the service actions listed above, which one(s) will your company perform as the prime contractor using its own personnel without subcontracting? 7b. With respect to the service actions listed above, which action(s) do you intend on subcontracting or using other than your company s own personnel? 7c. Of those services that will be performed, approximately what percentage will be paid to the subcontractor(s)? GSA Contract Number, if applicable. Fill out the price estimate below ITEM NUMBER DESCRIPTION OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT 00001 512.00 EA __________________ __________________ Base Period-Compounded sterile preparations (Chemo Meds) Contract Period: Base POP Begin: 12-01-2025 POP End: 11-30-2026 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 00002 81.00 EA __________________ __________________ Base period-Delivery Fee Contract Period: Base POP Begin: 12-01-2025 POP End: 11-30-2026 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 00003 12.00 MO __________________ __________________ Base period-Monthly retention fee Contract Period: Base POP Begin: 12-01-2025 POP End: 11-30-2026 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 01001 512.00 EA __________________ __________________ Option year 1-Compounded sterile preparations (Chemo Meds) Contract Period: Option 1 POP Begin: 12-01-2026 POP End: 11-30-2027 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 01002 81.00 EA __________________ __________________ Option year 1- delivery Fee Contract Period: Option 1 POP Begin: 12-01-2026 POP End: 11-30-2027 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 01003 12.00 MO __________________ __________________ Option year 1- Monthy retention fee Contract Period: Option 1 POP Begin: 12-01-2026 POP End: 11-30-2027 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 02001 512.00 EA __________________ __________________ Option year 2-Compounded sterile preparations (Chemo Meds) Contract Period: Option 2 POP Begin: 12-01-2027 POP End: 11-30-2028 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 02002 81.00 EA __________________ __________________ Option year 2- delivery Fee Contract Period: Option 2 POP Begin: 12-01-2027 POP End: 11-30-2028 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 02003 12.00 MO __________________ __________________ Option year 2- Monthy retention fee Contract Period: Option 2 POP Begin: 12-01-2027 POP End: 11-30-2028 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 03001 512.00 EA __________________ __________________ Option year 3-Compounded sterile preparations (Chemo Meds) Contract Period: Option 3 POP Begin: 12-01-2028 POP End: 11-30-2029 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 03002 81.00 EA __________________ __________________ Option year 3- delivery Fee Contract Period: Option 3 POP Begin: 12-01-2028 POP End: 11-30-2029 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 03003 12.00 MO __________________ __________________ Option year 3- Monthy retention fee Contract Period: Option 3 POP Begin: 12-01-2028 POP End: 11-30-2029 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 04001 512.00 EA __________________ __________________ Option year 4-Compounded sterile preparations (Chemo Meds) Contract Period: Option 4 POP Begin: 12-01-2029 POP End: 11-30-2030 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 04002 81.00 EA __________________ __________________ Option year 4- delivery Fee Contract Period: Option 4 POP Begin: 12-01-2029 POP End: 11-30-2030 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology 04003 12.00 MO __________________ __________________ Option year 4- Monthy retention fee Contract Period: Option 4 POP Begin: 12-01-2029 POP End: 11-30-2030 PRINCIPAL NAICS CODE: 456110 - Pharmacies and Drug Retailers PRODUCT/SERVICE CODE: Q501 - Medical - Anesthesiology GRAND TOTAL __________________ *Failure to provide the information requested above (items 1-9) will be considered non-responsive and will not be considered a viable source. RFQ number 36C26126Q0052 has been assigned and shall be referenced on all correspondence regarding this announcement. The Government will use this information when determining its business type decision. This synopsis is not to be construed as a commitment by the Government and no contract will be awarded as a direct result of this Sources Sought announcement. Notes: Contractors must have a current registration in the System for Award Management (SAM) at https://sam.gov/SAM/ To become a Certified VOSB or SDVOSB, visit https://veterans.certify.sba.gov/.
Q509--CHEMO THERAPY COMPOUNDING 570-26-1-625-0002 is a federal acquisition solicitation issued by DEPARTMENT OF VETERANS AFFAIRS. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.